Establishment Labs Holdings (ESTA) Profit After Tax Growth (3y) (2020 - 2026)
Powered by 
Analysis
Establishment Labs Holdings (ESTA) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 21.98% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 22.89% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 49.66% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | -7.65% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 15.46% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | 11.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.14% |
| Mar 31, 2026 | -3.87% |
| Dec 31, 2025 | 42.23% |
| Sep 30, 2025 | 15.70% |
| Jun 30, 2025 | 23.53% |
| Mar 31, 2025 | -51.69% |
| Dec 31, 2024 | -34.50% |
| Sep 30, 2024 | -4.36% |
| Jun 30, 2024 | -47.79% |
| Mar 31, 2024 | -32.61% |
| Dec 31, 2023 | -53.76% |
| Sep 30, 2023 | -90.34% |
| Jun 30, 2023 | -16.94% |
| Mar 31, 2023 | 12.38% |
| Dec 31, 2022 | -34.64% |
| Sep 30, 2022 | -13.36% |
| Jun 30, 2022 | -60.11% |
| Mar 31, 2022 | 18.05% |
| Dec 31, 2021 | -10.51% |
| Sep 30, 2021 | -136.57% |